Search Results 161-170 of 17354 for Teratogenic

1. Durvalumab and Grid Therapy for the Treatment of Non-small Cell Lung Cancer in Patients Who Progressed During or After Treatment With the PACIFIC Regimen - Mayo Clinic

   Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

2. Oxaliplatin, Leucovorin Calcium, and Fluorouracil with or without Celecoxib in Treating Patients with Stage III Colon Cancer Previously Treated with Surgery - Mayo Clinic

   ... teratogenic effects of FOLFOX on the developing fetus. Age and performance status. ECOG performance status 0, 1 or 2. Age at least 18 years. Required initial ...

3. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

   Patients must not be pregnant due to the potential teratogenic side effects of the protocol treatment. Women of reproductive potential and men must have ...

4. Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma - Mayo Clinic

   Not pregnant and not nursing, because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects. Therefore, for women of ...

5. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

   * Due to risks of fetal and teratogenic adverse events as seen in animal studies, a negative pregnancy test must be obtained in females of childbearing ...

6. How Lutathera attacks neuroendocrine tumors - Mayo Clinic

   Lutathera, the first FDA -approved peptide receptor radionuclide therapy, or PRRT , allows for precision targeting of NETs cells. Lutathera consists mainly of ...

7. Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

   ... teratogenic effects on the developing fetus and newborn are unknown. Pregnant women; Nursing women; Men or women of childbearing potential who are unwilling to ...

8. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   Pregnant women are excluded from this study because atezolizumab is an investigational agent with the unknown potential for teratogenic or abortifacient ...

9. A Study to Evaluate T-DM1 With or Without Abemaciclib in Women and Men with HER2-positive Advanced or Metastatic Breast Cancer - Mayo Clinic

   ... teratogenic potential of the therapy utilized in this trial. Appropriate methods of birth control include abstinence, oral contraceptives, implantable ...

10. Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors - Mayo Clinic

    Participation eligibility · Pregnancy or breastfeeding. · Pregnant or breast-feeding women will not be entered on this study due to risks of fetal and teratogenic ...